Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/03/2013US8598200 KAT II inhibitors
12/03/2013US8598199 Octahydropentalene compounds as chemokine receptor antagonists
12/03/2013US8598196 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
12/03/2013US8598195 Peptidomimetic compounds
12/03/2013US8598194 Polycyclic agents for the treatment of respiratory syncytial virus infections
12/03/2013US8598193 Polycyclic agents for the treatment of respiratory syncytial virus infections
12/03/2013US8598192 Hydroxylamine substituted imidazoquinolines
12/03/2013US8598190 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
12/03/2013US8598189 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
12/03/2013US8598188 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer
12/03/2013US8598187 Arylamide pyrimidone compounds
12/03/2013US8598185 Unitary pharmaceutical dosage form
12/03/2013US8598184 Protein kinase inhibitors
12/03/2013US8598181 Modulators of ATP-binding cassette transporters
12/03/2013US8598180 Tetrahydroindolone derivatives for treatment of neurological conditions
12/03/2013US8598179 Pyrazole-carboxamide derivatives as P2Y12 antagonists
12/03/2013US8598178 Controlled release sterile injectable aripiprazole formulation and method
12/03/2013US8598177 Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
12/03/2013US8598176 Pyridazine compound and use thereof
12/03/2013US8598175 Heteroarylamide pyrimidone derivatives
12/03/2013US8598174 Pyridazinones, method of making, and method of use thereof
12/03/2013US8598173 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for treating tumors
12/03/2013US8598172 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
12/03/2013US8598171 Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
12/03/2013US8598170 Dual-acting oxazole antihypertensive agents
12/03/2013US8598169 Biaryl compositions and methods for modulating a kinase cascade
12/03/2013US8598168 Inhibitors of histone deacetylase
12/03/2013US8598167 Substituted 6,5-fused bicyclic heteroaryl compounds
12/03/2013US8598166 Polysubstituted derivatives of 6-heteroarylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof
12/03/2013US8598164 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
12/03/2013US8598163 Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders
12/03/2013US8598162 Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders
12/03/2013US8598160 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/03/2013US8598159 Therapeutic pyrazoloquinoline derivatives
12/03/2013US8598158 Fused tricyclic compounds for the treatment of inflammatory disorders
12/03/2013US8598156 Chemical compounds
12/03/2013US8598155 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
12/03/2013US8598154 Pyridyl-amine fused azadecalin modulators
12/03/2013US8598153 Method of treatment using fatty acid synthesis inhibitors
12/03/2013US8598152 Co-crystals of tramadol and coxibs
12/03/2013US8598151 Solid solution inducing layer for weak epitaxy growth of non-planar phthalocyanine
12/03/2013US8598150 Composition and method for affecting obesity and related conditions
12/03/2013US8598149 Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
12/03/2013US8598148 Synthesis of tetracyclines and analogues thereof
12/03/2013US8598146 Methods for identifying modulators of protein kinase C-epsilon (PKCε) and method of treatment of aberrant glucose metabolism associated therewith
12/03/2013US8598145 Mitochondrially delivered anti-cancer compounds
12/03/2013US8598144 Method of administering hyaluronan formulation for the amelioration of osteoarthritis
12/03/2013US8598142 Sulfated depolymerized derivatives of expolysaccharides (EPS) from mesophilic marine bacteria, method for preparing the same, and uses thereof in tissue regeneration
12/03/2013US8598141 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
12/03/2013US8598138 Amphiphilic nucleotide cochleate compositions and methods of using the same
12/03/2013US8598132 Glycosylated indolocarbazoles, method for obtaining same and uses thereof
12/03/2013US8598131 Method for treatment of lung infections by administration of aminoglycosides by aerolisation
12/03/2013US8598130 Insecticidal combinations
12/03/2013US8598129 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
12/03/2013US8598128 Fructosylated puerarin, and preparation method and use thereof
12/03/2013US8598119 Methods and compositions for sleep disorders and other disorders
12/03/2013US8598116 Treatment of influenza virus infection
12/03/2013US8598086 3-halo-(arly)-4-iminotetrahydropicolinates and their use as herbicides
12/03/2013US8598078 Condensed anthran I lami de derivatives as insecticides
12/03/2013US8597904 Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition
12/03/2013US8597902 Peptide protection against ultraviolet light toxicity
12/03/2013US8597876 Method of treating HIV infection
12/03/2013US8597701 Transcription modulator compositions
12/03/2013US8597698 Formulations for treatment of skin disorders
12/03/2013US8597683 Modified release tranexamic acid formulation
12/03/2013US8597681 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
12/03/2013US8597672 Owl effigy
12/03/2013US8597666 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
12/03/2013US8597665 Chimeric immunomodulatory compounds and methods of using the same-IV
12/03/2013US8597654 Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod
12/03/2013US8597645 Cancer treatment with endothelin receptor antagonists
12/03/2013US8597642 Tablettable formulations of lipophilic health ingredients
12/03/2013US8597633 Subcutaneous delivery of poly(oxazoline) conjugates
12/03/2013US8597632 Anionic oligosaccharide conjugates
12/03/2013US8597631 Linear self-eliminating oligomers
12/03/2013US8597616 Dry powder drug delivery formulations, methods of use, and devices therefore
12/03/2013CA2723470C Nasal administration of benzodiazepines
12/03/2013CA2694235C Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
12/03/2013CA2691917C Crystalline pyridazine compound
12/03/2013CA2677185C Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
12/03/2013CA2658327C Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses
12/03/2013CA2651039C Hyaluronic acid binary mixtures and therapeutic use thereof
12/03/2013CA2637408C Foam-forming composition
12/03/2013CA2626567C Method of preventive on-demand hormonal contraception
12/03/2013CA2621830C 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
12/03/2013CA2615049C Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
12/03/2013CA2613477C Thiol-sensitive positive inotropes
12/03/2013CA2611529C Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
12/03/2013CA2611312C Organic compounds
12/03/2013CA2603509C Crystal form of asenapine maleate
12/03/2013CA2599411C Enzyme inhibitors
12/03/2013CA2594202C Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent
12/03/2013CA2583499C Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
12/03/2013CA2572057C A photoactive biocompatible coating composition
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
12/03/2013CA2570780C Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
12/03/2013CA2567801C Diarylalkanes as potent inhibitors of binuclear enzymes
12/03/2013CA2539446C 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/03/2013CA2532859C Use of rotigotine for the treatment of depression
12/03/2013CA2530302C Novel aminobenzophenone compounds